(Q40722705)

23 September 2017

1 reference

title

The pharmacogenetics of the selective serotonin reuptake inhibitors (English)

1 reference

23 September 2017

K Brøsen

1

1 reference

PubMed ID

8124052

23 September 2017

language of work or name

1 reference

1 December 1993

1 reference

Journal of Molecular Medicine

23 September 2017

1 reference

23 September 2017

71

1 reference

23 September 2017

1002-1009

1 reference

23 September 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00180032

23 September 2017

0 references

cites work

Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification

1 reference

12 December 2020

Fluvoxamine is a potent inhibitor of cytochrome P4501A2

1 reference

12 December 2020

Fluvoxamine-tricyclic antidepressant interaction

1 reference

12 December 2020

The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine

1 reference

12 December 2020

Fluoxetine and norfluoxetine are potent inhibitors of P450IID6--the source of the sparteine/debrisoquine oxidation polymorphism

1 reference

12 December 2020

The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer

1 reference

12 December 2020

Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms

1 reference

12 December 2020

The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature

1 reference

12 December 2020

Citalopram: interaction studies with levomepromazine, imipramine, and lithium

1 reference

12 December 2020

Inhibition by fluoxetine of cytochrome P450 2D6 activity.

1 reference

12 December 2020

Interaction of fluoxetine with tricyclic antidepressants

1 reference

12 December 2020

Toxic Interaction Between Fluvoxamine and Sustained Release Theophylline in an 11-Year-Old Boy

1 reference

12 December 2020

Extremely slow metabolism of amitriptyline but normal metabolism of imipramine and desipramine in an extensive metabolizer of sparteine, debrisoquine, and mephenytoin

1 reference

12 December 2020

Inhibitors of imipramine metabolism by human liver microsomes

1 reference

12 December 2020

Interaction between fluvoxamine and imipramine/desipramine in four patients

1 reference

12 December 2020

Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction

1 reference

12 December 2020

The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes

1 reference

12 December 2020

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

1 reference

12 December 2020

Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects

1 reference

12 December 2020

Major pathway of imipramine metabolism is catalyzed by cytochromes P-450 1A2 and P-450 3A4 in human liver

1 reference

12 December 2020

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

1 reference

12 December 2020

The relationship between paroxetine and the sparteine oxidation polymorphism

1 reference

12 December 2020

Clinical pharmacokinetics of selective serotonin reuptake inhibitors

1 reference

12 December 2020

[Possible interaction between theophylline and fluvoxamine]

1 reference

12 December 2020

Inhibition by paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine

1 reference

12 December 2020

Simultaneous determination of fluoxetine and norfluoxetine enantiomers in biological samples by gas chromatography with electron-capture detection

1 reference

12 December 2020

Tricyclic antidepressant plasma levels after fluoxetine addition.

1 reference

12 December 2020

Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: Nonlinearity and relation to the sparteine oxidation polymorphism

1 reference

12 December 2020

Clinical significance of the sparteine/debrisoquine oxidation polymorphism

1 reference

12 December 2020

Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00180032

1 reference

23 September 2017

1 reference

PubMed ID

8124052